X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-19 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $276.21 | -16,600 | 865,334 | -2% | -$4,585,138 | |||||
2025-03-20 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $7.85 | -20,000 | 991,974 | -2% | -$157,000 | ||||||
| M | 2025-03-19 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.00 | -2,101 | 298,594 | -1% | -$105,050 | |||||
2025-03-18 | OFIX | Orthofix Medical Inc. | Vitale Lucas | CP, BOO | S - Sale | $16.60 | -4,287 | 135,317 | -3% | -$71,164 | ||||||
2025-03-18 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $16.60 | -296 | 42,521 | -1% | -$4,914 | ||||||
2025-03-17 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale | $8.04 | -1,759 | 309,077 | -1% | -$14,142 | ||||||
| D | 2025-03-17 | TMCI | Treace Medical Concepts, Inc. | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $7.97 | -50,000 | 364,081 | -12% | -$398,460 | |||||
2025-03-17 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $70.33 | -352 | 22,997 | -2% | -$24,756 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $57.06 | -5,475 | 173,070 | -3% | -$312,404 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $57.06 | -733 | 107,991 | -1% | -$41,825 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $57.06 | -247 | 63,133 | 0% | -$14,094 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $57.06 | -316 | 61,473 | -1% | -$18,031 | ||||||
2025-03-18 | BDX | Becton Dickinson & Co | Byrd Richard | EVP, Pres Interventional | S - Sale | $230.00 | -459 | 6,952 | -6% | -$105,570 | ||||||
2025-03-14 | GUTS | Fractyl Health, Inc. | Royan Ajay | Dir, 10% | P - Purchase | $1.28 | +17,901 | 6,430,102 | 0% | +$22,980 | ||||||
2025-03-17 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $9.75 | -1,018 | 52,540 | -2% | -$9,926 | ||||||
2025-03-17 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $9.75 | -2,615 | 124,449 | -2% | -$25,496 | ||||||
2025-03-14 | GUTS | Fractyl Health, Inc. | Barnes Kelly Ann | Dir | P - Purchase | $1.30 | +31,000 | 31,000 | New | +$40,210 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Gerritzen Daniel J | GC, Secretary | S - Sale | $24.86 | -5,310 | 110,767 | -5% | -$132,007 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Bailey David R | Pres, CEO | S - Sale | $24.86 | -6,620 | 319,155 | -2% | -$164,573 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Hite Fred | COO, CFO | S - Sale | $24.86 | -6,443 | 207,989 | -3% | -$160,173 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Odle Gregory A | Pres of Scoliosis | S - Sale | $24.86 | -5,359 | 148,788 | -3% | -$133,225 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Hauser Joseph W | Pres Trauma, Def. Correction | S - Sale | $24.86 | -5,300 | 137,663 | -4% | -$131,758 | ||||||
2025-03-14 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.00 | -5,151 | 300,695 | -2% | -$257,550 | ||||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Schulman Amy W | Dir | P - Purchase | $1.17 | +8,550 | 8,550 | New | +$9,964 | ||||||
| M | 2025-03-13 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.45 | -49,024 | 783,294 | -6% | -$71,085 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.45 | -75,989 | 1,431,326 | -5% | -$110,184 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.45 | -193,913 | 4,115,845 | -4% | -$281,174 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.45 | -59,887 | 875,867 | -6% | -$86,836 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.45 | -49,024 | 685,775 | -7% | -$71,085 | |||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Bradley William | Dir | P - Purchase | $1.26 | +16,129 | 16,129 | New | +$20,358 | ||||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Conaway Samuel | Dir | P - Purchase | $1.17 | +8,550 | 8,550 | New | +$9,964 | ||||||
2025-03-14 | XAIR | Beyond Air, Inc. | Carey Robert | Dir | P - Purchase | $0.25 | +1,000,000 | 5,553,490 | +22% | +$250,050 | ||||||
2025-03-13 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale | $7.89 | -54,596 | 440,178 | -11% | -$430,762 | ||||||
2025-03-13 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale | $7.89 | -4,106 | 310,836 | -1% | -$32,396 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $70.38 | -14,076 | 360,793 | -4% | -$990,670 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $70.38 | -13,000 | 105,602 | -11% | -$914,941 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $70.38 | -12,001 | 123,481 | -9% | -$844,632 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $70.38 | -11,176 | 115,805 | -9% | -$786,568 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $70.38 | -32,498 | 372,029 | -8% | -$2,287,212 | ||||||
| DM | 2025-03-12 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale+OE | $80.42 | -6,529 | 3,753 | -63% | -$525,053 | |||||
| M | 2025-03-12 | SGHT | Sight Sciences, Inc. | Raheja Manohar K. | EVP, Research, Development | P - Purchase | $2.66 | +20,000 | 155,000 | +15% | +$53,250 | |||||
2025-03-13 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $13.04 | -1,044,295 | 7,810,588 | -12% | -$13,618,129 | ||||||
2025-03-12 | BDX | Becton Dickinson & Co | Byrd Richard | EVP, Pres Interventional | S - Sale | $224.91 | -1,940 | 7,411 | -21% | -$436,325 | ||||||
| D | 2025-03-10 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale+OE | $7.80 | -81,446 | 494,774 | -14% | -$635,279 | |||||
2025-03-10 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | S - Sale | $9.72 | -165,121 | 483,107 | -25% | -$1,604,976 | ||||||
2025-03-10 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $9.72 | -27,994 | 816,500 | -3% | -$272,102 | ||||||
| D | 2025-03-11 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $23.61 | -18,020 | 197,184 | -8% | -$425,510 | |||||
| D | 2025-03-11 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale+OE | $23.61 | -15,100 | 208,778 | -7% | -$356,549 | |||||
2025-03-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $230.36 | -1,000 | 90,864 | -1% | -$230,360 | ||||||
| M | 2025-03-10 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $45.02 | -12,806 | 305,846 | -4% | -$576,578 | |||||
2025-03-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $73.83 | -7,000 | 135,482 | -5% | -$516,830 | ||||||
2025-03-07 | TNDM | Tandem Diabetes Care Inc | Kyrillos Jean-Claude | EVP, COO | P - Purchase | $18.12 | +10,538 | 10,538 | New | +$190,966 | ||||||
2025-03-10 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $2.87 | -3,000 | 138,053 | -2% | -$8,621 | ||||||
| D | 2025-03-10 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $239.31 | -9,745 | 19,353 | -33% | -$2,332,096 | |||||
| D | 2025-03-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $229.20 | -8,009 | 457,562 | -2% | -$1,835,692 | |||||
2025-03-07 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.50 | -27,457 | 832,318 | -3% | -$41,131 | ||||||
2025-03-07 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.50 | -33,999 | 1,507,315 | -2% | -$50,931 | ||||||
2025-03-07 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.50 | -60,984 | 4,309,758 | -1% | -$91,354 | ||||||
2025-03-07 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.50 | -31,148 | 935,754 | -3% | -$46,660 | ||||||
2025-03-07 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.50 | -26,139 | 734,799 | -3% | -$39,156 | ||||||
| D | 2025-03-06 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $24.77 | -88,439 | 865,283 | -9% | -$2,190,848 | |||||
2025-03-06 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $24.80 | -1,048 | 146,651 | -1% | -$25,995 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Berry Lance A | EVP, CFO | S - Sale | $24.80 | -4,909 | 153,431 | -3% | -$121,764 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $24.80 | -2,618 | 207,968 | -1% | -$64,939 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $24.80 | -1,603 | 115,880 | -1% | -$39,761 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $24.80 | -2,124 | 196,112 | -1% | -$52,685 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $61.31 | -3,641 | 61,789 | -6% | -$223,230 | ||||||
2025-03-06 | RCEL | Avita Medical, Inc. | McNamara Robert | Dir | P - Purchase | $8.30 | +11,000 | 56,749 | +24% | +$91,300 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $61.31 | -3,588 | 63,380 | -5% | -$219,980 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $61.31 | -3,662 | 108,724 | -3% | -$224,517 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $61.31 | -15,916 | 178,545 | -8% | -$975,810 | ||||||
2025-03-06 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $10.83 | -33,732 | 668,977 | -5% | -$365,318 | ||||||
2025-03-07 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $10.64 | -12,691 | 6,118,503 | 0% | -$135,032 | ||||||
| D | 2025-03-05 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $283.59 | -61,600 | 853,958 | -7% | -$17,468,917 | |||||
| A | 2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | |||||
| A | 2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | |||||
2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | ||||||
2025-03-05 | ATRC | Atricure, Inc. | Prange Karen | Dir | S - Sale | $38.12 | -6,100 | 17,828 | -25% | -$232,532 | ||||||
| M | 2025-03-04 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $13.01 | -1,374,635 | 8,854,883 | -13% | -$17,880,070 | |||||
2025-03-05 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $227.71 | -2,000 | 75,218 | -3% | -$455,420 | ||||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P | Pres, CEO | S - Sale+OE | $103.85 | -34,320 | 1,191,650 | -3% | -$3,564,069 | |||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $103.58 | -5,361 | 26,971 | -17% | -$555,292 | |||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | S - Sale+OE | $102.90 | -30,000 | 38,945 | -44% | -$3,087,000 | |||||
2025-03-04 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale | $92.00 | -3,142 | 2,607 | -55% | -$289,064 | ||||||
2025-03-04 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $4.48 | -1,867 | 610,053 | 0% | -$8,364 | ||||||
2025-03-04 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $4.48 | -377 | 526,805 | 0% | -$1,689 | ||||||
2025-03-05 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | P - Purchase | $17.43 | +9,914 | 222,404 | +5% | +$172,801 | ||||||
2025-03-05 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $25.29 | -472 | 172,743 | 0% | -$11,935 | ||||||
| D | 2025-03-04 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale+OE | $1.58 | -66,292 | 405,198 | -14% | -$104,885 | |||||
| D | 2025-03-04 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $1.55 | -10,780 | 905,828 | -1% | -$16,693 | |||||
| D | 2025-03-04 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale+OE | $1.55 | -23,023 | 3,230,000 | -1% | -$35,651 | |||||
| DM | 2025-03-04 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $1.57 | -69,042 | 493,862 | -12% | -$108,658 | |||||
| DM | 2025-03-03 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $1.57 | -57,546 | 394,373 | -13% | -$90,571 | |||||
| D | 2025-03-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale+OE | $287.43 | -600 | 66,539 | -1% | -$172,458 | |||||
2025-03-03 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $285.48 | -50 | 5,573 | -1% | -$14,274 | ||||||
2025-03-03 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $287.42 | -12,000 | 326,819 | -4% | -$3,448,993 | ||||||
| D | 2025-03-03 | PEN | Penumbra Inc | Yuen Maggie | CFO | S - Sale+OE | $286.00 | -2,000 | 16,143 | -11% | -$571,995 | |||||
| DM | 2025-03-03 | PEN | Penumbra Inc | Shiu Lambert | Chief Accounting Officer | S - Sale+OE | $285.73 | -7,789 | 33,269 | -19% | -$2,225,583 | |||||
| D | 2025-02-28 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale+OE | $8.41 | -2,111 | 314,942 | -1% | -$17,743 | |||||
2025-03-03 | LUNG | Pulmonx Corp | Joshi Mehul | CFO, PAO | S - Sale | $7.12 | -14,384 | 221,986 | -6% | -$102,414 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |